Funktionsmenü_neu


Hauptnavigation


Sub-Navigation
Klickpfad

Investor News 2000

Here you find Investor News of year 2000.
In year 2000 no Ad-hoc messages have been issued.

Publications of the previous years are offered in the Archive Overview.

To view the PDF documents you will need the Acrobat Reader. Please click here to download the free Adobe Acrobat Reader software.

Receive our IR news via E-Mail, RSS Feed or SMS.

  

December 19, 2000

Bayer and Lyondell to build production facility in RotterdamLyondell_po11_e.pdf

December 08, 2000

Bayer not working on takeover defenseValue_e.pdf

December 06, 2000

Bayer set to become world's leading manufacturer of polycarbonate with MakrolonMakrolon_e.pdf

November 17, 2000

Bayer Signs Hemophilia Gene Therapy Deal with AvigenAvigen_e.pdf

November 16, 2000

A very successful first three quarters9M2000_e.pdf

November 10, 2000

Third Quarter 2000 Consensus EstimateConsQ300.pdf

November 08, 2000

ALKA-SELTZER PLUS LIQUI-GELS AND ALKA-SELTZER ANTACIDS ARE PPA-FREEAlkaSeltzer.pdf

November 06, 2000

New Drug Application Filed for Intravenous Formulation of the Antibiotic Moxifloxacin in Treating Community-Acquired Respiratory Tract InfectionsAveloxIV_e.pdf

October 25, 2000

Bayer makes its capital instruments more flexibleEMTN_e.pdf

October 24, 2000

Bayer: Acquisition of Sybron Chemicals successfully completedSybron2_e.pdf

October 24, 2000

MILLENNIUM AND BAYER INDUSTRIALIZING DRUG DISCOVERY PROCESS THROUGH ONGOING SUCCESSFUL RESEARCH ALLIANCEMillennium2_e.pdf

October 17, 2000

Bayer acquires new fungicide from NovartisFlint_e.pdf

October 16, 2000

H.C. Starck acquires U.S. group CSMCSM_e.pdf

nach oben
  

October 16, 2000

LION bioscience and Bayer Pioneer Linkage Between Chemistry & Genomics To Speed Life Science Discovery ResearchLion2_e.pdf

October 11, 2000

Bayer and DuPont to build new PBT polymer plant#PBT_e.pdf

September 14, 2000

Bayer Supervisory Board extends CEO's contractHolding_e.pdf

September 05, 2000

Bayer to acquire paper chemicals business of Cytec Industries Inc.Cytec_e.pdf

September 04, 2000

Bayer acquires antibiotic in France from Aventis and Yamanouchijosamycin_e.pdf

August 30, 2000

Bayer to Acquire Sybron Chemicals Inc.,U.S. Producer of Polymers and Specialty ChemicalsSybron_e.pdf

August 30, 2000

Calcium Channel Blockers Reduce Cardiovascular Risk in Hypertension, a WHO / ISH Analysis SaysAdalat_e.pdf

August 16, 2000

Development of a Recombinant Aerosol Formulation for AAT Deficiencyppl_e.pdf

August 11, 2000

Bayer sells Solar subsidiary to SolarWorldSolar.pdf

August 08, 2000

1st Half 2000 Consensus Estimate1H2000_Estimates_e.pdf

August 07, 2000

KOGENATE Bayer approved by the European CommissionKogenate_e.pdf

nach oben
  

July 18, 2000

Bayer awards worldwide license rights for moxifloxacin for the treatment of eye and ear infectionsAlcon_e.pdf

June 28, 2000

FDA Approves Bayer's Next Generation Formulation of Recombinant Factor VIII (rFVIII) for Hemophilia AKGFS_e.pdf

June 26, 2000

New marketplace for logistics servicesChemlogistic_e.pdf

June 14, 2000

Bayer divests U.S. livestock vaccines business unitTG_USA_e.pdf

June 02, 2000

Calcium antagonists save lives in hypertensive patients with additional risk factors: ADALAT INSIGHT trial resultsAdalat_INSIGHT_e.pdf

May 26, 2000

Bayer plans to sell Erdölchemie shareholding to Deutsche BPErdlchemie_e.pdf

nach oben
Current Events
Friday, February 26, 2010
2009 Annual ReportRemind
Friday, February 26, 2010
Financial News ConferenceRemind